Literature DB >> 14463231

Iproniazid, nialamide, and meprobamate in angina pectoris. A double-blind trial.

D LEAK, D G JULIAN.   

Abstract

Entities:  

Keywords:  ANGINA PECTORIS/therapy; IPRONIAZID/therapy; MEPROBAMATE

Mesh:

Substances:

Year:  1962        PMID: 14463231      PMCID: PMC1958946          DOI: 10.1136/bmj.1.5292.1593

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  14 in total

1.  Tersavid in angina pectoris. A sequential clinical trial.

Authors:  F M MURPHY; J M BARBER; S J KILPATRICK
Journal:  Lancet       Date:  1961-01-21       Impact factor: 79.321

2.  Iproniazid and angina pectoris.

Authors:  E R JOLLY
Journal:  Circulation       Date:  1959-07       Impact factor: 29.690

3.  Iproniazid in angina pectoris; a double-blind study.

Authors:  M SHOSHKES; E J ROTHFELD; M C BECKER; A FINKELSTEIN; C C SMITH; F W WACHTEL
Journal:  Circulation       Date:  1959-07       Impact factor: 29.690

4.  Use of iproniazid in ischaemic angina pectoris.

Authors:  M K TOWERS; P WOOD
Journal:  Br Med J       Date:  1958-11-01

5.  Iproniazid in the anginal syndrome due to coronary disease.

Authors:  A M MASTER; E DONOSO
Journal:  Ann N Y Acad Sci       Date:  1959-09-17       Impact factor: 5.691

6.  Assay of anti-anginal agents. I. A curve analysis with multiple control periods.

Authors:  S L COLE; H KAYE; G C GRIFFITH
Journal:  Circulation       Date:  1957-03       Impact factor: 29.690

7.  Iproniazid (marsilid) in angina pectoris.

Authors:  A M MASTER
Journal:  Am Heart J       Date:  1958-10       Impact factor: 4.749

8.  [Serendipity and angina pectoris; preliminary report on a therapeutic finding].

Authors:  T CESARMAN
Journal:  Arch Inst Cardiol Mex       Date:  1957 Sep-Oct

9.  Observations on the use of meprobamate in cardiovascular disorders.

Authors:  S SHAPIRO
Journal:  Angiology       Date:  1957-12       Impact factor: 3.619

10.  Nialamide (Niamid) in angina pectoris; report of a double-blind trial.

Authors:  K D ALLANBY; A G COX; K S MACLEAN; T M PRICE; N SOUTHWELL
Journal:  Lancet       Date:  1961-01-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.